Agenda Co-chairs Dr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMA Moderator Dr Gaya Manori Gamhewage, Director, Department of Communication, WHO Welcoming Dr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMA Presentation: WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults Dr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr
|naltrexone 50 mg tablet uses in hindi
Increasing evidence underscores the critical role of diet and nutrition, not only in supporting physical health and body composition but also in promoting brain health
Glasgow 2026 More Opinion NST TV NST Podcast Vouchers 1Klassifieds Get Audio+ HOT FM Kool FM Eight FM FLY FM MOLEK FM Nation Nation NST Special Regional NST Viral View All Asean Business Times Home Corporate Economy Feature Insight Property Car Bikes Trucks SME ESG View All Life & Times Groove Sunday Vibes JOM
Share how GLP-1s work, what aesthetic changes clients might notice, and which treatments can help
These collections will allow deeper analysis of biomarkers and other factors that can be correlated with self-reported fatigue assessments and wearable data to provide a fuller picture of the biological effects of the drug
